Solaxa

Biotechnology Research • Bethesda, Maryland, United States • 11-20 Employees

Company overview

Headquarters	7272 Wisconsin Ave, Floor 9, Bethesda, Maryland 20814, US
Phone number	+16282664770
Website	solaxa.com
NAICS	541714
Keywords	Biotechnology, Research, Pharmaceuticals, Neurology, Therapeutics, CNS, Nerves, Peripheral Neuropathy, Cipn, Ataxia, Nerve Injury, Sca27B, Spinocerebellar Ataxia
Founded	2021
Employees	11-20
Socials

Key Contact at Solaxa

Christian Walker

Ceo & Founder

Solaxa Email Formats

Solaxa uses 2 email formats. The most common is {first initial} (e.g., j@solaxa.com), used 83.3% of the time.

Format	Example	Percentage
{first initial}	j@solaxa.com	83.3%
{first name}	john@solaxa.com	16.7%

About Solaxa

Belonging starts in the body. When nerve damage occurs, it disrupts sensation that affects physical function and severs bonds with what brings us joy and makes us who we are. We restore what it means to be human – feeling alive and connected to the world again. Solaxa is a clinical-stage biopharmaceutical company developing life-altering solutions that reignite function lost from neurodegenerative disease and nerve damage. We help adults and children get back the confidence in movement and the ability to participate in activities that bring a sense of belonging. As a public benefit corporation, we have a responsibility to deliver impactful solutions; we serve people for the greater good. We measure success by the human experience — by delivering solutions and care that help people regain independence and the ability to connect with the world around them. Because when you feel at home in your body, you belong everywhere.

Solaxa revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	$670,000